OBJECTIVE: This article reviews topics discussed during the Fifth International Forum for Liver MRI (with a focus on gadoxetic acid-enhanced MRI), which was held in Munich, Germany, in September 2011. CONCLUSION: Growing evidence shows that gadoxetic acid-enhanced MRI has high sensitivity and specificity for diagnosing liver tumors. Hepatobiliary phase imaging adds new information for the characterization of borderline lesions. However, there is a need to develop standardized criteria for interpretation of gadoxetic acid-enhanced MRI in patients with cirrhosis or other risk factors for hepatocellular carcinoma.
|Autori interni:||BARTOLOZZI, CARLO|
|Autori:||Zech CJ; Bartolozzi C; Bioulac-Sage P; Chow PK; Forner A; Grazioli L; Huppertz A; Laumonier H; Min Lee J; Murakami T; Ricke J; Sirlin CB.|
|Titolo:||Consensus report of the Fifth International Forum for Liver MRI|
|Anno del prodotto:||2013|
|Digital Object Identifier (DOI):||10.2214/AJR.12.9491|
|Appare nelle tipologie:||1.1 Articolo in rivista|